Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms
Ketamine, a racemic mixture consisting of (S)-and (R)-ketamine, has been in clinical use
since 1970. Although best characterized for its dissociative anesthetic properties, ketamine …
since 1970. Although best characterized for its dissociative anesthetic properties, ketamine …
Detection and analysis of chiral molecules as disease biomarkers
The chirality of small metabolic molecules is important in controlling physiological processes
and indicating the health status of humans. Abnormal enantiomeric ratios of chiral molecules …
and indicating the health status of humans. Abnormal enantiomeric ratios of chiral molecules …
Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers
D Matveychuk, RK Thomas… - Therapeutic …, 2020 - journals.sagepub.com
Ketamine, a drug introduced in the 1960s as an anesthetic agent and still used for that
purpose, has garnered marked interest over the past two decades as an emerging treatment …
purpose, has garnered marked interest over the past two decades as an emerging treatment …
Efficacy and safety of perioperative application of ketamine on postoperative depression: a meta-analysis of randomized controlled studies
J Guo, D Qiu, H Gu, X Wang, K Hashimoto… - Molecular …, 2023 - nature.com
Ketamine, a commonly used general anesthetic, can produce rapid and sustained
antidepressant effect. However, the efficacy and safety of the perioperative application of …
antidepressant effect. However, the efficacy and safety of the perioperative application of …
A brief history of the development of antidepressant drugs: from monoamines to glutamate.
TM Hillhouse, JH Porter - Experimental and clinical …, 2015 - psycnet.apa.org
Major depressive disorder (MDD) is a chronic, recurring, and debilitating mental illness that
is the most common mood disorder in the United States. It has been almost 50 years since …
is the most common mood disorder in the United States. It has been almost 50 years since …
Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis
Abstract (R, S)-ketamine (ketamine) and its enantiomer (S)-ketamine (esketamine) can
produce rapid and substantial antidepressant effects. However, individual response to …
produce rapid and substantial antidepressant effects. However, individual response to …
Mechanisms of action and persistent neuroplasticity by drugs of abuse
ER Korpi, B den Hollander, U Farooq… - Pharmacological …, 2015 - Elsevier
Adaptation of the nervous system to different chemical and physiologic conditions is
important for the homeostasis of brain processes and for learning and remembering …
important for the homeostasis of brain processes and for learning and remembering …
Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review
ND Iadarola, MJ Niciu, EM Richards… - … advances in chronic …, 2015 - journals.sagepub.com
Current pharmacotherapies for major depressive disorder (MDD) and bipolar depression
(BDep) have a distinct lag of onset that can generate great distress and impairment in …
(BDep) have a distinct lag of onset that can generate great distress and impairment in …
New targets for rapid antidepressant action
Current therapeutic options for major depressive disorder (MDD) and bipolar disorder (BD)
are associated with a lag of onset that can prolong distress and impairment for patients, and …
are associated with a lag of onset that can prolong distress and impairment for patients, and …
D-Serine: potential therapeutic agent and/or biomarker in schizophrenia and depression?
MAB MacKay, M Kravtsenyuk, R Thomas… - Frontiers in …, 2019 - frontiersin.org
D-Serine is a potent co-agonist at the NMDA glutamate receptor and has been the object of
many preclinical studies to ascertain the nature of its metabolism, its regional and cellular …
many preclinical studies to ascertain the nature of its metabolism, its regional and cellular …